Cooper Financial Group Bio Rad Laboratories, Inc. Transaction History

Cooper Financial Group

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$418.69 - $503.0 $191,341 - $229,871	457 New	457 $218,000
Q1 2022 Apr 12, 2022	SELL	$524.57 - $735.42 $425,426 - $596,425	-811 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$708.84 - $794.68 $7,088 - $7,946	10 Added 1.25%	811 $613,000
Q3 2021 Oct 06, 2021	BUY	$657.71 - $825.77 $38,804 - $48,720	59 Added 7.95%	801 $598,000
Q2 2021 Jul 12, 2021	BUY	$576.64 - $649.04 $23,642 - $26,610	41 Added 5.85%	742 $478,000
Q1 2021 May 17, 2021	SELL	$547.01 - $662.35 $7,658 - $9,272	-14 Reduced 1.96%	701 $400,000
Q4 2020 Feb 16, 2021	SELL	$510.68 - $643.45 $9,702 - $12,225	-19 Reduced 2.59%	715 $417,000
Q3 2020 Oct 09, 2020	SELL	$454.43 - $535.6 $24,539 - $28,922	-54 Reduced 6.85%	734 $378,000
Q2 2020 Jul 15, 2020	BUY	$334.87 - $493.06 $263,877 - $388,531	788 New	788 $356,000

458

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.48B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

Stay updated on Cooper Financial Group with notifications on news.